Glucose Transporter Type Deficiency Syndrome
📧 Sign up to get email alerts when something new happens for Glucose Transporter Type Deficiency Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome [Phase 2]
A Phase II exploratory trial evaluating fucose supplementation for GLUT1 deficiency syndrome; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome [NA]
A clinical trial evaluating red blood cell exchange transfusion as a treatment for GLUT1 deficiency syndrome has been suspended while furthe…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS [Phase 2]
Phase II open-label study assessing the safety and potential efficacy of Triheptanoin in patients with glucose transporter type 1 deficiency…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) [Phase 2]
Phase 2 study update evaluating a diet-based treatment for Glucose Transporter Type 1 Deficiency Syndrome (GLUT1DS), with epilepsy as a co-o…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: The Glucose Transporter Type I Deficiency (G1D) Registry
A registry study tracking Glucose transporter type 1 deficiency syndrome (GLUT1 DS) has completed enrollment.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome [Phase 2]
Phase 2 open-label trial of triheptanoin in Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) [Phase 2]
Phase 2 clinical trial of Triheptanoin (UX007) for Glucose Transporter Type 1 Deficiency Syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS) [Phase 2]
Phase 2 trial evaluating long-term safety and efficacy of UX007 in Glucose Transporter Type 1 Deficiency Syndrome (GLUT1 DS) was terminated;…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) [Phase 3]
Phase 3 crossover trial evaluating UX007 for movement disorders in Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) was terminated …
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) [Phase 1]
Phase 1 trial update for a treatment targeting GLUT1 deficiency syndrome (Glucose Transporter Type 1 Deficiency Syndrome) has completed with…
-
CLINICAL_TRIALS withdrawal · 2019-02-15Clinical Trial Update: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of Triheptanoin (C7 oil) for GLUT1 deficiency has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
The document reports a clinical trial update where UX007 (triheptanoin) was used to treat a single patient with Glucose transporter type 1 d…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome [Phase 2]
A Phase 2 pilot study of triheptanoin in patients with glucose transporter type 1 deficiency syndrome is described, with the trial status cu…